Michele  Szilagyi Profile Image

Eli Lilly and Company

Program Year

Fellow: 2022

Areas of Practice

  • Biomedical/Life Sciences
  • Biomedical/Life Sciences > Biological Products
  • Biomedical/Life Sciences > Combination Products
  • Biomedical/Life Sciences > FDA Regulatory/Compliance
  • Biomedical/Life Sciences > Healthcare Research
  • Biomedical/Life Sciences > Pharmaceuticals
  • Compliance
  • Compliance > FCPA
  • Compliance > Internal Controls, Policies, Processes & Programs
  • Compliance > M&A Due Diligence
  • Compliance > Whistleblower
  • Government & Regulatory
  • Government & Regulatory > FDA Regulatory Compliance
  • Healthcare
  • Healthcare > Digital Health
  • Healthcare > False Claims Act
  • Healthcare > Fraud & Abuse
  • Healthcare > Health Information Technology
  • Healthcare > Healthcare Compliance
  • Healthcare > Healthcare Fraud and Abuse
  • Healthcare > Healthcare Mergers, Acquisitions, & Joint Ventures
  • Healthcare > Healthcare Regulatory & Public Policy
  • Healthcare > HIPAA
  • Healthcare > Medical Devices
  • Healthcare > Medicare/Medicaid Reimbursement
  • Healthcare > Physician Agreements
  • Healthcare > Privacy Statutes
  • Mergers & Acquisitions
  • Mergers & Acquisitions > Healthcare M&A

Law School

Indiana University Maurer School of Law